Cargando…

Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing

Detalles Bibliográficos
Autores principales: Wei, Junqiang, Liao, Zhichao, Zhao, Gang, Nahar, Nazmun, Zhang, Chao, Lu, Jia, Yang, Yun, Yang, Jilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170657/
https://www.ncbi.nlm.nih.gov/pubmed/32227592
http://dx.doi.org/10.1002/cac2.12020
_version_ 1783523932918251520
author Wei, Junqiang
Liao, Zhichao
Zhao, Gang
Nahar, Nazmun
Zhang, Chao
Lu, Jia
Yang, Yun
Yang, Jilong
author_facet Wei, Junqiang
Liao, Zhichao
Zhao, Gang
Nahar, Nazmun
Zhang, Chao
Lu, Jia
Yang, Yun
Yang, Jilong
author_sort Wei, Junqiang
collection PubMed
description
format Online
Article
Text
id pubmed-7170657
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71706572020-04-21 Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing Wei, Junqiang Liao, Zhichao Zhao, Gang Nahar, Nazmun Zhang, Chao Lu, Jia Yang, Yun Yang, Jilong Cancer Commun (Lond) Letter to the Editor John Wiley and Sons Inc. 2020-03-30 /pmc/articles/PMC7170657/ /pubmed/32227592 http://dx.doi.org/10.1002/cac2.12020 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letter to the Editor
Wei, Junqiang
Liao, Zhichao
Zhao, Gang
Nahar, Nazmun
Zhang, Chao
Lu, Jia
Yang, Yun
Yang, Jilong
Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title_full Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title_fullStr Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title_full_unstemmed Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title_short Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
title_sort clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170657/
https://www.ncbi.nlm.nih.gov/pubmed/32227592
http://dx.doi.org/10.1002/cac2.12020
work_keys_str_mv AT weijunqiang clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT liaozhichao clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT zhaogang clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT naharnazmun clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT zhangchao clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT lujia clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT yangyun clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing
AT yangjilong clinicopathologicalfeaturesofpseudomyogenichemangioendotheliomaandprecisiontherapybasedonwholeexomesequencing